Qurratul Ann Warsi – Biography
Last update: 13 days agoExecutive profile
Qurratul was Vice President and Head of Clinical Development at Antiva Biosciences, and Senior Medical Director, Clinical Development at Priovant Therapeutics. Qurratul Ann Warsi joined Freya Biosciences in 2026.
Qurratul Ann Warsi is currentlyVice President and Head of Clinical Development at Freya Biosciences - View - Freya Biosciences org chart
Create your alert
to follow the career of Qurratul Ann Warsi.
Education
In 2017, Qurratul Ann Warsi completed a Master in Advance Studies in Clinical Research, Epidemiology and Biostatistics at University of California, San Francisco.
They have also studied at University of California, San Francisco :
Find more alumni from University of California, San Francisco
More about Qurratul Ann Warsi
Do you need to know more about Qurratul Ann Warsi? More results.
Participate
- Suggest a professional link about Qurratul Ann Warsi
- Delete any non-relevant links for Qurratul Ann Warsi
Social media
- Qurratul Ann Warsi on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Qurratul Ann Warsi
The colleagues of Qurratul Ann Warsi
Company Colleagues
- At Freya Biosciences, Qurratul Ann Warsi has 10 colleagues including Colleen Acosta (CEO & Director), David Stern (Director)…
Industry Colleagues
- In the Biotechnology industry, Qurratul Ann Warsi has 35,919 colleagues in 2,427 companies located in 45 countries. 17,064 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Qurratul Ann Warsi.
Get in Touch
Here are a few tips for establishing great contacts.
